MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.780
+0.150 (9.20%)
At close: Oct 2, 2026, 4:00 PM EDT
1.920
+0.140 (7.87%)
After-hours: Oct 2, 2026, 7:30 PM EDT
MediciNova Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, MediciNova stock has a consensus rating of "Strong Buy" and an average price target of $8.25. The average 1-year stock price forecast is 363.48% higher than the current stock price, while the lowest is $6.00 (+237.08%) and the highest is $11 (+517.98%).
Price Target: $8.25 (+363.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MediciNova stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $6 | Buy | Reiterates | $6 | +237.08% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +461.80% | Sep 28, 2026 |
| Roth MKM | Roth MKM | Buy Initiates $6 | Buy | Initiates | $6 | +237.08% | Sep 17, 2026 |
Financial Forecast
Revenue This Year
730.00K
from 409.66K
Increased by 78.20%
Revenue Next Year
333.33K
from 730.00K
Decreased by -54.34%
EPS This Year
-0.26
from -0.24
EPS Next Year
-0.52
from -0.26
EPS and Forward PE are based on non-GAAP adjusted numbers.